SILO Pharma Inc
SILO
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.43M
Close$
$0.42
93.1% downside
Current Fair Value
93.1% downsideOvervalued by 93.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.43 Million |
|---|---|
| Enterprise Value | $-401,561.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.5 |
| Beta | 0.77 |
| Outstanding Shares | 13,709,211 |
Return
| Return on Equity | -85.24% |
|---|---|
| Return on Assets | -69.01% |
| Return on Invested Capital | -75.87% |
Valuation & Multiples
| P/E Ratio | -1.21 |
|---|---|
| PEG | -2.03 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -5.57 |
| Enterprise Value to EBIT | 0.08 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.18 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
$18,000
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
$18,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 12.60%▼ 0.41% |
|---|---|
| Total Invested | $379,779▼ 7.90% |
| Investors Holding | 14▼ 1.00% |
ESG Score
No data
About SILO Pharma Inc
1 employees